Browse > Article

A Single Oral Dose Toxicity Test of GST in Beagle Dogs  

Lee, Chul-wha (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Yang, Won-kyung (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Jung, In-chul (Dept. of Neuropsychology, College of Korean Medicine, Dae-Jeon University)
Jin, Mi-rim (Institute of Traditional Medicine and Bioscience, Dae-Jeon University)
Kim, Seung-hyeong (Institute of Traditional Medicine and Bioscience, Dae-Jeon University)
Park, Yang-chun (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.37, no.1, 2016 , pp. 8-15 More about this Journal
Abstract
Objectives: To provide information on the safety of GST (Gami-Sasangja-tang), we carried out a single oral dose-increasing toxicity test of GST in beagle dogs.Materials and Methods: Six beagle dogs (three males and three females) were randomly assigned to two groups (experimental group: n=4, control group: n=2). The experimental group (two males, two females) was given oral doses of GST in increasing order (1,250, 2,500, and 5,000 mg/kg) at three-day intervals. After administration, the participants’ mortality, clinical signs, and body weight changes were monitored for two weeks. After two weeks, all dogs were sacrificed for autopsy.Results: Temporary vomiting was observed according to increasing dosage (n=1, 250 mg/kg; n=4, 2,500 and 5,000 mg/kg). Transient diarrhea was observed on the second and third dosing day (n=1, 2,500 mg/kg; n=2, 5,000 mg/kg). Temporary salivation was noted on the third dosing day (n=3, 5,000 mg/kg). Compound-colored stool was observed in all dogs fed the GST on all dosing days and also on the following days. We found no mortality and no abnormalities in the clinical signs, body weight, and gross findings in any of the dogs tested.Conclusions: The maximum tolerated dose was over 5,000 mg/kg for both male and female dogs.
Keywords
GST (Gami-Sasangja-tang); safety; single oral dose-increasing toxicity; beagle dogs;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002;22:1-24.
2 Hong SJ. Korean ISAAC committee in Korean academy of pediatric allergy and respiratory disease. Pediatr Allergy Respir Dis(Korea) 2007;17 Suppl 1:S55-66.
3 Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. J Allergy Clin Immunol 2008;121(4):947-54.   DOI
4 건강보험정책연구원. 국민건강보험 보도자료[cited 2014-03-26] Available from: http://www.nhic.or.kr./cms/board/board/Board.jsp?act=VIEW&communityKey=B0039&boardId=22846
5 김진혜, 김혜원, 박천욱, 이철헌. 성인 아토피 피부염 환자의 삶의 질. 대한피부과학회지 2011;49(11):983-92.
6 Watson W, Kapur S. Atopic dermatitis. Allergy Asthma & Clinical Immunology 2011;7(Suppl 1):S4.   DOI
7 김태윤. 아토피 피부염 치료의 최신 경향. 소아 알레르기 및 호흡기 학회지 2009;19(3):209-19.
8 진실공. 외과정종. 북경: 인민위생출판사; 1964, p. 244.
9 Gam BS, Kim IR, Kim HC, Guk YB, Park YG, Seo BI, et al. Bon-Cho-Hak. Seoul: Younglimsa; 1991, p. 197, 227, 308, 517, 631-3.
10 Park BK, Park YC, Jung IC, Kim SH, Choi JJ, Do M, et al. Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis. J Ethnopharmacol 2015;165:54-60.   DOI
11 한종민, 홍지희, 이혜영, 정인철, 진미림, 김승형, 등. GST의 Sprague-Dawley Rat를 이용한 단회 경구투여 독성시험 및 4주 반복 경구투여 용량결정시험. Korean J Orient Int Med 2013;34(4):349-61.
12 김윤하, 김준영, 한종민, 이혜영, 정인철, 진미림, 등. GST 추출물의 Sprague-Dawley Rat를 이용한 13주 반복 경구투여 독성시험 및 4주 회복시험. 대한한방내과학회지 2014;35(3):223-43.
13 이철화, 한종민, 이미영, 정인철, 진미림, 김승형, 등. GST 추출물의 유전독성평가. 동의생리병리학회지 2014;28(6):621-9.   DOI
14 Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651-7.   DOI
15 Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics 2008;122:812-24.   DOI
16 Nicol NH, Boguniewicz M. Successful strategies in atopic der-matitis management. Dermatol Nurs 2008;Suppl:3-18.
17 Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines”. J Am Acad Dermatol 2004;50:391-404.   DOI
18 Park Y. Status of clinical practice on diagnosis and management of atopic dermatitis in Korea: a questionnaire survey of physicians. Allergy Asthma Respir Dis 2013;1(3):257-65.   DOI
19 Yun YH, Choi IH. A study on the development of traditional Korean Medicine clinical practice guideline for atopic deramtitis. J Korean Orient Med Opthalmol & Otolaryngol & Dermatol 2012;25(2):38-48.   DOI
20 식품의약품안전처. 식품의약품안전처고시 제 2015-82호 (2015년 11월 11일) 의약품등의 독성시험기준. 2015.
21 Ha CS, Son HY, Kang BH, Cha SW, Park JI, Han SS. A study of hematology and serum chemistry in beagle dogs. Korean J Lab Ani Sci 1995;11(2):153-8.
22 Yang H, Yoon M, Kim J, Cho S. Acute oral toxicity of phlorotannins in beagle dogs. Korean J Fisheries & Aquatic Sci 2014;47(4):356-62.   DOI
23 이제헌, 서부일, 박지하. 백부근의 독성에 관한 문헌적 고찰. 제한동의학술원논문집 2010;8(1):23-32.
24 김종대, 최해윤. 백부근이 흰쥐의 간 및 신장에 미치는 조직학적 연구. 대한한의학회지 1999;20(2):45-53.